Clinical Trial

Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

Recruiting
View on ClinicalTrials.gov →
Summary
During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.
Trial Details
NCT Number NCT07418450
Lead Sponsor University of Vienna
Conditions Lung Cancer (Diagnosis)
Enrollment 30 participants
Start Date 2025-11-05
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-18